PRESS RELEASE: MyMeds&Me Reportum® solution deployed by Pfizer Inc.

London, UK, 9 March, 2015: MyMeds&Me, a leading SaaS provider of web-based adverse event and product quality complaint capture solutions for life sciences, today announced the deployment of the Reportum® solution across all Pfizer safety call centre sites for the U.S. market. This marks the signing of a hosting agreement with Pfizer to adopt the Reportum® solution via Software as a Service (SaaS) delivery.
Pfizer has deployed the Reportum® solution from MyMeds&Me as the standard for the U.S. Safety Call Centre, to support prompt availability of high quality safety data from reporters, including consumers, patients and healthcare professionals.

Supporting Quotes:

“Improving processes with an easy to use electronic solution is key to maintaining high levels of quality by reducing potential transcription errors and managing the calls in a structured way to obtain as much information as possible with the first contact.”, said Pfizer VP, Rob Goodwin.

“Our selection of the Reportum® solution reflects our commitment to streamline our call handling processes with state of the art electronic solutions.”

“We are delighted to announce the SaaS deployment and successful roll-out of the Reportum® solution across Pfizer Safety Call Centre sites for the United States”, said Andrew Rut, CEO at MyMeds&Me.

“We believe that Pfizer’s commitment to standardisation on this market-leading, innovative solution underlines the significance of the Reportum® solution to the pharmacovigilance market”.

About MyMeds&Me:

MyMeds&Me is the leading SaaS provider of web-based adverse event and product quality capture solutions for life sciences. Our mission is to improve adverse event management and understanding of product quality by simplifying the process for all. Our vision is to develop and deliver web-based data capture solutions in a short timeframe via SaaS that support the transformation of the end-to-end pharmacovigilance process, providing benefits to Pharma companies, CROs and regulatory agencies whilst improving assessment of patient safety. Website:  Twitter: @mymedsandme

Leave a Reply

Your email address will not be published. Required fields are marked *